Predictive factors in pregnancies with reduced fetal movements: a pilot study.


Journal

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
ISSN: 1476-4954
Titre abrégé: J Matern Fetal Neonatal Med
Pays: England
ID NLM: 101136916

Informations de publication

Date de publication:
Dec 2022
Historique:
entrez: 5 9 2022
pubmed: 6 9 2022
medline: 8 9 2022
Statut: ppublish

Résumé

Pregnancies with reduced fetal movements (RFM) are at risk for poor neonatal outcomes and stillbirth. To investigate whether Doppler measurements or angiogenic factors are good predictors of adverse neonatal outcomes in pregnancies with RFM. This is a prospective pilot cohort study of 3243 women seeking care for RFM. Standard care was carried out in all cases. An extra Doppler examination was performed in 128 women to assess the flow in the middle cerebral artery, the umbilical artery, and the uterine artery. In 62/128 pregnancies, a maternal blood sample was obtained for angiogenic and antiangiogenic factors. The composite neonatal outcome of the study was one or more of the following factors: Apgar score <7 at 5', arterial aPh in the umbilical cord ≤7.1, transfer to Neonatal Intensive Care (NICU), stillbirth, and small for gestational age (SGA). In 14.1% (18/128) of the Doppler group and 11.7% (365/3115) of the standard care group, there was an adverse neonatal outcome ( Angiogenic factors may have a place in the prediction of the neonatal outcome of RFM pregnancies. The prediction model's capacity was driven by parity. The obstetrical intervention rate increased with additional Doppler examinations.

Sections du résumé

BACKGROUND UNASSIGNED
Pregnancies with reduced fetal movements (RFM) are at risk for poor neonatal outcomes and stillbirth.
AIM UNASSIGNED
To investigate whether Doppler measurements or angiogenic factors are good predictors of adverse neonatal outcomes in pregnancies with RFM.
METHODS UNASSIGNED
This is a prospective pilot cohort study of 3243 women seeking care for RFM. Standard care was carried out in all cases. An extra Doppler examination was performed in 128 women to assess the flow in the middle cerebral artery, the umbilical artery, and the uterine artery. In 62/128 pregnancies, a maternal blood sample was obtained for angiogenic and antiangiogenic factors. The composite neonatal outcome of the study was one or more of the following factors: Apgar score <7 at 5', arterial aPh in the umbilical cord ≤7.1, transfer to Neonatal Intensive Care (NICU), stillbirth, and small for gestational age (SGA).
RESULTS UNASSIGNED
In 14.1% (18/128) of the Doppler group and 11.7% (365/3115) of the standard care group, there was an adverse neonatal outcome (
CONCLUSION UNASSIGNED
Angiogenic factors may have a place in the prediction of the neonatal outcome of RFM pregnancies. The prediction model's capacity was driven by parity. The obstetrical intervention rate increased with additional Doppler examinations.

Identifiants

pubmed: 36062520
doi: 10.1080/14767058.2020.1855135
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4543-4551

Auteurs

Irene Sterpu (I)

Department of Clinical Science and Education, Karolinska Institute, Soder Hospital, Stockholm, Sweden.
Department of Obstetrics and Gynecology, Soder Hospital, Stockholm, Sweden.

Christina Pilo (C)

Department of Obstetrics and Gynecology, Soder Hospital, Stockholm, Sweden.

Pelle G Lindqvist (PG)

Department of Clinical Science and Education, Karolinska Institute, Soder Hospital, Stockholm, Sweden.
Department of Obstetrics and Gynecology, Soder Hospital, Stockholm, Sweden.

Helena Åkerud (H)

Department of Immunology, Genetics, and Pathology, Minerva Fertility Clinic, Uppsala University, Uppsala, Sweden.

Eva Wiberg Itzel (E)

Department of Clinical Science and Education, Karolinska Institute, Soder Hospital, Stockholm, Sweden.
Department of Obstetrics and Gynecology, Soder Hospital, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH